3,5-Bis(benzylidene)-1-methyl-4-piperidone

ID: ALA515242

PubChem CID: 5386934

Max Phase: Preclinical

Molecular Formula: C20H19NO

Molecular Weight: 289.38

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1C/C(=C\c2ccccc2)C(=O)/C(=C/c2ccccc2)C1

Standard InChI:  InChI=1S/C20H19NO/c1-21-14-18(12-16-8-4-2-5-9-16)20(22)19(15-21)13-17-10-6-3-7-11-17/h2-13H,14-15H2,1H3/b18-12+,19-13+

Standard InChI Key:  GHSYIDDDJZZVKM-KLCVKJMQSA-N

Molfile:  

     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
    6.4992   -6.8340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2137   -7.2465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9281   -6.8340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9281   -6.0090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2137   -5.5965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4992   -6.0090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2137   -4.7715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4992   -4.3590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4992   -3.5340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7847   -3.1215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2137   -3.1215    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0702   -3.5340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0702   -4.3590    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7847   -4.7715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7847   -2.2965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0702   -1.8840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3558   -2.2965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6413   -1.8840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6413   -1.0590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3558   -0.6465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0702   -1.0590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3558   -4.7715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  9 11  2  0
  8 14  1  0
  5  6  2  0
 10 12  1  0
  6  1  1  0
 12 13  1  0
  1  2  2  0
 13 14  1  0
  5  7  1  0
 10 15  2  0
  3  4  2  0
 15 16  1  0
  7  8  2  0
 16 17  2  0
 17 18  1  0
  8  9  1  0
 18 19  2  0
  4  5  1  0
 19 20  1  0
  9 10  1  0
 20 21  2  0
 21 16  1  0
  2  3  1  0
 13 22  1  0
M  END

Alternative Forms

  1. Parent:

    ALA515242

    Cyto9B4

Associated Targets(Human)

HSC-3 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSC-4 (439 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSC-2 (771 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2-CD81 (19978 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium berghei (192651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 289.38Molecular Weight (Monoisotopic): 289.1467AlogP: 3.67#Rotatable Bonds: 2
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.38CX LogP: 4.28CX LogD: 4.28
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.79Np Likeness Score: -0.26

References

1. Pati HN, Das U, Das S, Bandy B, De Clercq E, Balzarini J, Kawase M, Sakagami H, Quail JW, Stables JP, Dimmock JR..  (2009)  The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones.,  44  (1): [PMID:18468733] [10.1016/j.ejmech.2008.03.015]
2. Antonova-Koch Y, Meister S, Abraham M, Luth MR, Ottilie S, Lukens AK, Sakata-Kato T, Vanaerschot M, Owen E, Jado JC, Maher SP, Calla J, Plouffe D, Zhong Y, Chen K, Chaumeau V, Conway AJ, McNamara CW, Ibanez M, Gagaring K, Serrano FN, Eribez K, Taggard CM, Cheung AL, Lincoln C, Ambachew B, Rouillier M, Siegel D, Nosten F, Kyle DE, Gamo FJ, Zhou Y, Llinás M, Fidock DA, Wirth DF, Burrows J, Campo B, Winzeler EA..  (2018)  Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.,  362  (6419): [PMID:30523084] [10.1126/science.aat9446]